Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 24;10(2):003698.
doi: 10.128f90/2023_003698. eCollection 2023.

Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome

Affiliations

Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome

Lídia Caley et al. Eur J Case Rep Intern Med. .

Abstract

Classical Ehlers-Danlos syndrome (cEDS) is one of the 13 subtypes of Ehlers-Danlos syndrome, which has the major clinical criteria of hyperextensibility skin, atrophic scars, and generalised joint hypermobility. The occurrence of aortic dissection has been described in some subtypes of Ehlers-Danlos, but it has a rare association with the cEDS subtype. This case report discusses a 39-year-old female with a past medical history of transposition of great arteries with a Senning repair at the age of 18 months and controlled hypertension with medication, who presents a spontaneous distal aortic dissection. The diagnosis of cEDS was made using the major criteria, and a novel frameshift mutation in COL5A1 was discovered. The reported case emphasises that in patients with cEDS, vascular fragility may be a complication.

Learning points: Classical Ehlers-Danlos is a rare autosomal dominant inherited connective disorder.Arterial dissections are rarely found in cEDS patients.Association of cEDS and vascular fragility can result from new type V collagen mutation.

Keywords: COL5A1 mutation; Classical Ehlers-Danlos syndrome; aortic dissection.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The authors declare there are no competing interests.

References

    1. Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175:8–26. - PubMed
    1. Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, et al. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat. 2012;33:1485–1493. - PubMed
    1. Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, et al. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: Identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet J Rare Dis. 2013;8:58. - PMC - PubMed
    1. Angwin C, Brady AF, Pope FM, Vandersteen A, Baker D, Cheema H, et al. Arterial complications in classical Ehlers-Danlos syndrome: A case series. J Med Genet. 2020;57:769–776. - PubMed
    1. Miklovic T, Sieg VC. Ehlers Danlos syndrome. Treasure Island, FL: StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549814/ - PubMed

LinkOut - more resources